Delphia (USA)’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,883
Closed -$265K 151
2023
Q2
$265K Buy
+3,883
New +$250K 0.42% 96
2022
Q1
Sell
-5,597
Closed -$276K 384
2021
Q4
$276K Buy
+5,597
New +$310K 0.29% 132

Other funds holding PRTA

Delphia (USA)'s PRTA Position: Q3 2023 in Review

Delphia (USA) sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 3,883 shares — an estimated $265K sold.

Delphia (USA) first reported a position in PRTA in Q4 2021 and held it in 2 quarters. The position peaked at $276K in Q4 2021. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

  • Delphia (USA) reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
  • Delphia (USA) sold 3,883 Prothena Corp shares in Q3 2023, an estimated $265K.
  • Delphia (USA) first reported a position in Prothena Corp in Q4 2021 and held it in 2 quarters.
  • Delphia (USA)'s Prothena Corp position peaked at $276K in Q4 2021.
  • 186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on Delphia (USA)'s 13F filing for Q3 2023, filed 15 Nov 2023.